Mercy Health – St. Charles Hospital is a hospital in Oregon, Ohio and is part of Mercy Health.

There are 390 beds in St. Charles Mercy Hospital.

During the past decade, St. Charles Mercy Hospital conducted 28 clinical trials. In the 10-year time frame, 28 clinical trials started and 156 clinical trials were completed, i.e. on average, 557.1% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 49 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "St. Charles Mercy Hospital" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 79 trials, followed by "National Cancer Institute (NCI)" with 69 trials sponsored, "SWOG Cancer Research Network" with 26 trials sponsored, "Radiation Therapy Oncology Group" with 18 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 18 trials sponsored. Other sponsors include 24 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "St. Charles Mercy Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 160 trials as a collaborator, "NRG Oncology" with 21 trials as a collaborator, "NCIC Clinical Trials Group" with 17 trials as a collaborator, "Cancer and Leukemia Group B" with 15 trials as a collaborator and "SWOG Cancer Research Network" with 12 trials as a collaborator. Other collaborators include 46 different institutions and companies that were collaborators in the rest 31 trials.

According to Clinical.Site data, the most researched conditions in "St. Charles Mercy Hospital" are "Breast Cancer" (39 trials), "Lung Cancer" (19 trials), "Unspecified Adult Solid Tumor, Protocol Specific" (15 trials), "Lymphoma" (11 trials) and "Prostate Cancer" (10 trials). Many other conditions were trialed in "St. Charles Mercy Hospital" in a lesser frequency.

Most popular intervention types in "St. Charles Mercy Hospital" are "Drug" (191 trials), "Other" (113 trials), "Biological" (87 trials), "Radiation" (44 trials) and "Procedure" (30 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (55 trials), "placebo" (35 trials), "Quality-of-Life Assessment" (23 trials), "Bevacizumab" (17 trials) and "Paclitaxel" (16 trials). Other intervention names were less common.

The vast majority of trials in "St. Charles Mercy Hospital" are 181 trials for "All" genders, 39 trials for "Female" genders and 12 trials for "Male" genders.

Currently, there are NaN active trials in "St. Charles Mercy Hospital". undefined are not yet recruiting, 6 are recruiting, 65 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 139 completed trials in St. Charles Mercy Hospital, undefined suspended trials, and 20 terminated clinical trials to date.

Out of the total trials that were conducted in St. Charles Mercy Hospital, 9 "Phase 1" clinical trials were conducted, 93 "Phase 2" clinical trials and 122 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".